EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
10.04
-0.44 (-4.20%)
At close: Jul 28, 2025, 4:00 PM
10.03
-0.01 (-0.10%)
After-hours: Jul 28, 2025, 4:10 PM EDT
EyePoint Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts that cover EyePoint Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $24.75, which forecasts a 146.51% increase in the stock price over the next year. The lowest target is $15 and the highest is $33.
Price Target: $24.75 (+146.51%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 17, 2025.
Analyst Ratings
The average analyst rating for EyePoint Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 4 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Initiates $28 | Buy | Initiates | $28 | +178.88% | Jun 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +119.12% | May 29, 2025 |
| Mizuho | Mizuho | Buy Maintains $30 → $26 | Buy | Maintains | $30 → $26 | +158.96% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 → $27 | Strong Buy | Maintains | $33 → $27 | +168.92% | May 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +228.69% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
41.19M
from 43.27M
Decreased by -4.81%
Revenue Next Year
17.89M
from 41.19M
Decreased by -56.57%
EPS This Year
-2.98
from -2.32
EPS Next Year
-3.01
from -2.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 69.8M | 60.8M | 251.0M | ||
| Avg | 41.2M | 17.9M | 85.8M | ||
| Low | 24.0M | n/a | 15.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 61.2% | 47.5% | 1,302.9% | ||
| Avg | -4.8% | -56.6% | 379.5% | ||
| Low | -44.5% | - | -12.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.15 | -1.42 | -1.88 | ||
| Avg | -2.98 | -3.01 | -2.86 | ||
| Low | -3.50 | -4.55 | -4.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.